Anebulo Pharmaceuticals (FRA:214) Float Percentage Of Total Shares Outstanding: 16.30% (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:214 Anebulo Pharmaceuticals Inc FRA:214
35 GF Score
Price €0.75
! 1 Warning Sign
View Full Analysis

What is Anebulo Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Anebulo Pharmaceuticals FRA:214 35 Float Percentage Of Total Shares Outstanding is 16.30% as of Aug. 01, 2026. GuruFocus rates FRA:214 with a GF Score™ of 35/100. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Anebulo Pharmaceuticals's float shares is 6.65 Mil. Anebulo Pharmaceuticals's total shares outstanding is 40.78 Mil. Anebulo Pharmaceuticals's float percentage of total shares outstanding is 16.30%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Anebulo Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Anebulo Pharmaceuticals's Institutional Ownership is 1.15%.

FRA:214
35GF Score
Anebulo Pharmaceuticals Inc FRA:214
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anebulo Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Anebulo Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=6.65/40.78
=16.30%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 16.30% mean?
Anebulo Pharmaceuticals (FRA:214) has a Float Percentage Of Total Shares Outstanding of 16.30% as of Aug. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Anebulo Pharmaceuticals and its competitors.
Is Anebulo Pharmaceuticals' Float Percentage Of Total Shares Outstanding too high?
Anebulo Pharmaceuticals' current Float Percentage Of Total Shares Outstanding is 16.30%. Overall, Anebulo Pharmaceuticals has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Anebulo Pharmaceuticals' Float Percentage Of Total Shares Outstanding compare to PHIO and COCP?
Anebulo Pharmaceuticals' Float Percentage Of Total Shares Outstanding of 16.30% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Anebulo Pharmaceuticals and its competitors. Anebulo Pharmaceuticals's current Float Percentage Of Total Shares Outstanding is 16.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anebulo Pharmaceuticals stock overvalued right now?
Anebulo Pharmaceuticals (FRA:214) has a current Float Percentage Of Total Shares Outstanding of 16.30%. The current Float Percentage Of Total Shares Outstanding is 16.30%. Anebulo Pharmaceuticals' overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Anebulo Pharmaceuticals (FRA:214), the current Float Percentage Of Total Shares Outstanding is 16.30% as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anebulo Pharmaceuticals Business Description

Other Exchanges ANEB:USA
Address 1017 Ranch Road 620 South, Suite 107, Lakeway, TX, USA, 78734
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
35GF Score

Get the complete analysis for FRA:214

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price